Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban for Microembolism in Stent-Assisted Coil Embolization
NCT05841147Phase 4Unknown
- Start
- Apr 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tirofiban in brain aneurysm (IA) (2 arms). Primary endpoint: Microembolism. Status: unknown.
02
Drugs
tirofiban
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on NCT05841147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05841147.